跳至主要内容
临床试验/NCT00630474
NCT00630474已完成4 期

Does Nasal Decongestion Improve Obstructive Sleep Apnea ?

University of Zurich2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2004年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
12
试验地点
2
主要终点
sleep related breathing disturbances sleep efficiency daytime sleepiness

研究概览

简要总结

Whether impaired nasal breathing contributes to sleep related breathing disturbances has not been known. Therefore, the purpose of the study is to compare the effect of xylometazoline, a drug that decongests the nasal mucosa when applied locally, with placebo in terms of sleep and nocturnal breathing and daytime performance.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Obstructive sleep apnea syndrome (excessive sleepiness, apnea/hypopnea index >10/h)
  • Chronic nasal congestion (complaint of impaired nasal breathing that interfered with subjective sleep quality on at least 3 nights per week during at least the last 3 months)

排除标准

  • Nasal surgery within the last 6 months
  • Current treatment with nasal decongestants or topical steroids
  • Sleep disorders other than obstructive sleep apnea
  • Internal medical or psychiatric disorders that interfered with sleep

研究组 & 干预措施

1

Active Comparator

nasal application of xylometazoline

干预措施: xylometazoline (Drug)

2

Placebo Comparator

nasal application of placebo

干预措施: xylometazoline (Drug)

结局指标

主要结局

sleep related breathing disturbances sleep efficiency daytime sleepiness

时间窗: at end of one week treatment

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验